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Abstract 
Background: A multi-disciplinary, international working subgroup of the Third Perioperative 
Quality Initiative (POQI) consensus meeting reviewed the (patho)physiology and 
measurement of arterial blood pressure (ABP), as applied to perioperative medicine.  
Methods: We addressed predefined questions by undertaking a modified Delphi analysis, in 
which primary clinical research and review articles were identified using MEDLINE. 
Strength of recommendations, where applicable, were graded by NICE guidelines. 
Results: Perioperative ABP management is a physiologically-complex challenge influenced 
by multiple factors: (i) ABP is the input pressure to organ blood flow, but is not the sole 
determinant of perfusion pressure; (ii) blood flow is often independent of changes in 
perfusion pressure, due to autoregulatory changes in vascular resistance; (iii) microvascular 
dysfunction uncouples microvascular blood flow from ABP (haemodynamic incoherence)  
From a practical clinical perspective, we identified that: (i) ambulatory measurement is the 
optimal method to establish baseline ABP; (ii) automated and invasive ABP measurements 
have inherent physiological and technical limitations; (iii) individualised ABP targets may 
change over time, especially during the perioperative period.  There remains a need for 
research in non-invasive, continuous arterial pressure measurements, macro- and 
microcirculatory control, regional perfusion pressure measurement and the development of 
sensitive, specific and continuous measures of cellular function to evaluate blood pressure 
management in a physiologically coherent manner. 
Conclusion: The multivariable, complex physiology contributing to dynamic changes in 
perioperative ABP may be underappreciated clinically. The frequently unrecognised 
dissociation between ABP, organ blood flow, microvascular and cellular function requires 
further research that develops a more refined, contextualized clinical approach to this routine 
measurement. 
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The measurement of arterial blood pressure is a fundamental tenet of modern perioperative 
practice, yet the limitations of using blood pressure to guide clinical management have long 
been recognised.1 With the increasing complexity of clinical interventions and 
cardiorespiratory comorbidity, the interpretation of this measurement has become 
increasingly challenging and scrutinized. The development of novel monitoring 
technologies,2 coupled with recent trials demonstrating the need for a reappraisal of chronic 
arterial hypertension management, 3 further demand a re-evaluation of applied bedside 
physiology to everyday perioperative practice. Here, we summarise the key aspects of blood 
pressure physiology relevant to the perioperative period by focussing on applied 
physiological principles to guide the rational interpretation of this common, but frequently 
over-simplified, clinical measure. We also provide tractable clinical examples that highlight 
the need for the constant re-evaluation of perioperative blood pressure regulation. 
 
Methods 
The Perioperative Quality Initiative (POQI) is an international, multidisciplinary non-profit 
organization that organizes consensus conferences on clinical topics related to perioperative 
medicine. Each conference assembles a collaborative group of diverse international experts 
from multiple healthcare disciplines who are tasked with using a modified Delphi technique to 
develop consensus-based recommendations in perioperative medicine.   
The POQI-3 consensus conference on perioperative blood pressure management took place in 
London, UK from July 1-3, 2017. The objective of POQI-3 was to produce consensus 
statements and practice recommendations pertaining to the definition and management of 
perioperative blood pressure, and to identify research priorities.  The participants in the POQI 
consensus meeting were recruited based on their expertise in perioperative medicine and blood 
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pressure management (see: Appendix 1). Conference participants were divided into four work 
groups; Group 1 reviewed the physiology and measurement of blood pressure with relevance 
to the perioperative setting, Groups 2, 3 and 4 were focused on pre- intra- and post-operative 
blood pressure, respectively.  
 
The POQI process is based on an established modified Delphi process used in the Acute 
Dialysis Quality Initiative (ADQI) conferences4 and includes the following iterative steps 
before (steps 1 and 2) and during (step 3) the conference: 1) building consensus around the 
most important questions related to the topic, 2) a literature review of the topic raised by each 
question, 3) sequential steps of content development and refinement until agreement is 
achieved and a consensus document is produced. This final step of content development and 
refinement involves a modified Deplhi process of alternating breakout and plenary sessions.  
In the breakout sessions, work groups addressed the issues in their assigned topic area and 
formulated consensus statements and practice receommendations. In the plenary sessions, the 
findings and deliberations of each work group are presented, debated, and refined. Consensus 
on some statements and recommendations may be achieved in the first plenary session. Other 
statements and recommendation required further refinement by the work groups before re-
presentation to the plenary group in the next cycle. At the end of the conference, plenery group 
members vote to signal either formal agreement with the final statements/recommendations, or 
signal their disagreement. In the latter case, a statement of disagreement would be included in 
the manuscript. All recommendations were unanimously approved, unless stated otherwise. 
 
This workgroup of the POQI-3 consensus meeting reviewed the (patho)physiology and 
measurement of arterial blood pressure (ABP) as applied to perioperative medicine. Prior to 
the meeting a literature search was conducted in medline based on predefined questions (see 
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Appendix 2).  
 
Results 
Consensus statement 1: Different measures and values of arterial blood pressure reflect 
multivariable, complex physiology that are not interchangable. 
Blood pressure is a composite measurement comprising several values with differing 
physiological roles and origins.  
Arterial blood pressure is determined by the interaction between left ventricular cardiac 
contraction, the hydraulic load of the arterial system and extravascular, intra-thoracic and 
intra-abdominal mechanical forces. 5 
 
Common measures of arterial blood pressure include systolic, diastolic, mean arterial and 
pulse pressure. These different measures are not constant and reflect fundamentally different 
components shaping the physiology of blood pressure regulation (Figure 1).6 Systolic 
pressure is the maximal aortic pressure achieved after the left ventricle has ejected blood into 
the aorta. During left ventricular relaxation and refilling, aortic pressure declines to a nadir, 
termed the diastolic blood pressure. Pulse pressure represents the difference between systolic 
and diastolic pressures, representing the interaction between stroke volume and arterial tone.7  
Systolic pressure is determined by the pattern and duration of left ventricular ejection 
(stroke volume), the compliance (distensibility) of the arterial vessels, the velocity of the 
pressure wave in large arteries and vasomotor tone in peripheral arteries, which regulates the 
magnitude of reflection of pressure waves.5 Increased transmission velocity of both the 
forward and reflected pressure waves leads to arrival of the reflected wave in the central aorta 
during systole, augmenting systolic pressure.8 Hypertension, the prevalence of which 
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increases with age, is primarily attributable to the loss of elasticity in central arteries.9  Hence, 
arterial stiffening augments systolic and pulse pressures. In essence, this means that central 
aortic pressure serves as a surrogate of ventricular wall tension, and is the most accurate 
measure of afterload. 
Systolic pressure increases progressively towards the peripheral arterial tree through 
augmentation of the arterial pulse wave. As systolic pressure rises, diastolic pressure falls 
slightly, due to branching vessels reflecting pressure waves in combination with the 
decreased arterial compliance of the distributing arteries.6 As a result of increased resistance 
and reduced compliance in smaller arteries and arterioles, the amplitude of pulsation 
decreases until becoming minimal in the capillaries.10 The capacitive (“reservoir”) function is 
determined by the compliance of the aorta and large elastic arteries and largely determines 
the morphology of the pulse waveform.11 The arterial reservoir declines with age as 
compliance falls, leading to changes in the aortic pressure waveform.  
Diastolic pressure depends on arterial compliance (stiffness), heart rate and the 
resistance and distribution of the vascular network, which is arranged in series and parallel. 
As humans age, diastolic pressure rises until ~50 years of age and then typically declines 
thereafter. Laminar and turbulent flow characteristics, as well as blood viscosity, also 
influence systolic and diastolic pressures. Taken together, changes in vascular tone and 
viscosity associated with pathology affect both the amplitude and timing of the reflected 
waves, meaning that measured peripheral pressures rarely equate to central arterial pressure. 
Therefore, when tone, viscosity or contractility vary rapidly, organ input pressure is unlikely 
to reflect central pressure. This, in part, explains the inconsistent and variable threshold 
values of blood pressure associated with pathophysiology. 
The clinical importance of calculating mean arterial pressure.  
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The mean arterial pressure (MAP) is the average pressure value during the arterial pulse 
pressure cycle. Since there is relatively low resistance in the arterial tree down to the smaller 
arteries, MAP declines by only a small degree as the aortic pressure pulse travels away from 
the aorta and to the distributing arteries.  According to Ohm’s law, MAP is a function of 
cardiac output and arterial resistance with the arterial resistance located primarily in the 
downstream small arteries and arterioles. Furthermore, this also means that MAP can be used 
as a reference value along the entire central arterial system to estimate organ input pressure. 
However, MAP does not accurately reflect left ventricular afterload because the hydraulic 
impedance encountered by the left ventricle comprises static (total peripheral resistance) and 
pulsatile elements more accurately quantified by the combination of hydraulic pressure, 
arterial elastance and compliance.  
 
Arterial blood pressure may be dissociated from intact autoregulation mechanisms. 
Across different organs, the maintenance of tissue perfusion requires autoregulatory 
mechanisms that counteract extreme variations in arterial pressure (Figure 2).12, 13 
Autoregulation in the cerebral circulation, for example, requires myogenic, neurogenic and 
metabolic feedback mechanisms to ensure adequate perfusion.14 However, interactions 
between these three regulatory mechanisms are poorly understood, particularly under 
anaesthesia and/or in the presence of systemic inflammation. Experimental data suggest that 
neurogenic (sympathetic autonomic) control is a key player in rapid cerebral autoregulatory 
adjustments during acute changes in arterial blood pressure.15 In hypertension, autoregulation 
is impaired -at least in part to impaired neurovascular responses to carbon dioxide,  compared 
with normotensive subjects.16 Hypertensive impairment of cerebral autoregulation may 
extend beyond a rightward shift, with a marked narrowing- or complete loss- of the plateau 
range of pressure over which constant flow is ensured.17  
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Circadian and neural/hormonal changes influence blood pressure over time. 
Circadian rhythms regulate cardiovascular physiology through alterations in metabolism, 
feeding, sleep and wakefulness, coupled with coordinated neurohormonal secretion.18 The 
master circadian clock situated in the suprachiasmatic nuclei of the hypothalamus is 
synchronized to the external environment primarily by signals from the visual system, 
providing information about light-dark cycles. Interoceptive stressors similarly shape 
circadian signalling. Beyond the brain, peripheral circadian clocks also regulate circadian 
oscillations.18 
Arterial pressure is substantially lower during sleep in normal healthy individuals.19  
Loss of central and/or peripheral diurnal rhythms that alter activity, metabolism and hence 
neurohormonal release, profoundly influence blood pressure and other cardiovascular 
functions that contribute to the development of cardiometabolic disease.20 Many 
(hypertensive) individuals fail to show such marked declines in blood pressure at night,21 a 
feature associated with end-organ damage and a higher incidence of cardiovascular 
complications.22 Acute inflammation and anaesthetic drugs are additional potent triggers for 
disrupting normal circadian regulation of arterial blood pressure.23  
 
Essential hypertension is a complex, multi-organ disease. 
The complexity of blood pressure regulation is amplified in an estimated 25% of adults  with 
essential hypertension.24 The uncoupling of mechanisms regulating blood volume, ventricular 
function, central and peripheral autonomic control, neurohormonal activation via the renin-
angiotensin aldosterone system, and endothelial release of nitric oxide disrupts blood pressure 
and/or blood pressure variability. The role of salt sensitivity in hypertensive individuals 
highlights the potential impact of increased sodium administration, which is a crucial 
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regulator of blood volume.25 Chronic systemic inflammation driven by perturbations in innate 
and adaptive immune cells acting at both vascular and non-vascular substrates further 
contribute to the multifaceted pathophysiology of hypertension.26 There is limited clinical 
data on how perioperative interventions are affected by, or impact on, various 
pathophysiological drivers of hypertension.  
 
Perioperative implications of consensus statement 1 
The contribution of blood pressure measurement to clinical management is dependent on the 
context within which that measurement occurs. A single BP measurement divorced from both 
acute and chronic clinical contexts is highly unlikely to provide clinically useful information.  
 
Consensus statement 2: Blood pressure is necessary to ensure adequate blood flow to 
meet cellular metabolic demands.  
An adequate blood flow that meets the metabolic demands of tissues is usually reflected by 
pulse pressure (reflecting stroke volume) and MAP (reflecting cardiac output) remaining 
within a population-defined normal range. Recent trials suggest that end-organ damage in 
chronic hypertension occurs at lower than previously accepted arterial blood pressure 
thresholds.3, 27 Moreover, within organs, significant heterogeneity in intra-organ blood flow 
occurs as a result of intrinsic variability in local microvascular resistance that is likely to be 
chiefly determined by regional and local metabolic requirements. Microcirculatory perfusion 
is frequently perturbed by acute hypotension for prolonged periods, even after brief episodes, 
resulting in metabolically compromised, dysoxic or hypoxic tissues.28 Despite evidence for 
cellular dysfunction following tissue hypoperfusion in vulnerable tissues, such as the gastric 
mucosa during controlled haemorrhage in healthy conscious volunteers, arterial blood 
pressure may remain within its’ normal range during significant hypovolemia.28 Thus, the 
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physiological response to hypovolemia maintains arterial pressure, which is dissociated from 
cardiac output for a variable period of time.29 Attempts to reverse hypotension may therefore 
not be effective in restoring microcirculatory perfusion.30 Loss of hemodynamic coherence 
between the macrocirculation and the microcirculation occurs when either spontaneously, or 
through clinical intervention, systemic blood pressure is restored yet deficiencies in 
microcirculatory perfusion and oxygen delivery persist.31 Macro- and microcirculatory 
incoherence is likely to promote therapeutic measures targeted towards macrovascular 
variables that potentially cause harm, such as the inappropriate administration of fluids and/or 
vasopressor drugs. This may explain why correcting macrovascular haemodynamic variables 
to normalize, or supranormalize, systemic oxygen delivery may be ineffective once systemic 
inflammation is established.32 33 Thus, even though macrovascular (systemic arterial pressure) 
parameters may appear to be adequate in both acute and chronic pathological states, this does 
not necessarily reflect intra-organ microvascular blood flow.  In other words, adequate blood 
pressure is necessary to ensure adequate blood flow to meet cellular metabolic demands, but 
is not sufficient to guarantee such flow. 
 
Perioperative implications of consensus statement 2.  
Blood pressure measurement alone cannot ensure that adequate blood flow meets cellular 
metabolic demands. Therefore, confirmatory measures are required to establish whether a 
particular clinical blood pressure target is adequate. Confirmatory measures may require 
simple (e.g. central- peripheral temperature gradient) and/or additional sophisticated 
measures (e.g. lactate, mixed venous oxygen saturation). 
 
Consensus statement 3: Blood flow is often independent of changes in perfusion 
pressure, as a consequence of autoregulatory changes in vascular resistance.  
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Within a broad range of organ-specific perfusion pressures, autoregulatory mechanisms 
ensure that flow is preserved (Figure 2). Pharmacological (e.g. anaesthetic agents) and 
pathological (e.g. sepsis) perturbation of autoregulatory control renders organ blood flow 
pressure dependent.34 These observations partly explain why perioperative complications are 
frequently observed in organs (kidney, heart, brain) that require highly autoregulated, yet 
individualised, control of blood pressure. Extremes of arterial pressure (hypotension, 
hypertension) are associated with perioperative injury in these organs.35  
 
Perioperative implications of consensus statement 3.  
A blood pressure reading deemed “normal”  for any individual may lead to the erroneous 
conclusion that this accurately reflects normovolaemia and/or adequate cardiac output. For 
example, progressive haemorrhage in surgical patients often fails to manifest as a decline in 
blood pressure when compensatory mechanisms are intact. Moreover, in the presence of 
concomitant pain or exogenous catecholamine infusion, blood pressure measurements may 
mask an injurious decline in organ perfusion. 
 
 
Consensus statement 4: Arterial blood pressure is the input pressure to organ blood 
flow, but is not the sole determinant of perfusion pressure. 
Total systemic vascular resistance has long been defined by electrical circuit theory, which 
assumes that a constant pressure decrease from input to output sites exists. However, 
laboratory and human studies demonstrate that two separate pressure gradients are likely to 
exist, enabled by the presence of Starling resistors residing within arteriolar or precapillary 
loci.  The arterial gradient is generated from the central arterial circuit to the critical closing 
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pressure, whilst a venous pressure gradient exists between mean systemic filling pressure to 
central venous pressure.(Figure 3) Therefore, the input pressure to an organ is determined by 
the difference between the central arterial pressure and organ specific arterial critical closing 
pressure, the pressure threshold that coincides with cessation of blood flow at an inflow 
pressure higher than outflow venous pressure. 36 Perfusion pressure to an organ is determined 
by the input pressure minus the outflow pressure, which in turn is determined by the 
surrounding organ pressure (e.g. interstitial pressure) and right atrial pressure.  Input pressure 
thresholds and outflow pressure vary significantly between organs, highlighting the 
importance of arterial and venous resistances which determine a “vascular waterfall” that 
ensures organ perfusion even in low-flow conditions.37 The presence of two separate, but in-
series vascular resistances, ensures that a pressure gradient within an organ (i.e. critical 
closing pressure >mean systemic filling pressure) is maintained for a finite period of time 
even during profound hypotension (when MAP decreases to the critical closing pressure). 
These data suggest that common perioperative scenarios such as hypotension - characterised 
by a short-lasting dissociation between MAP and cardiac output - are unlikely to be rationally 
addressed by conventional clinical intervention(s). (Figure 3) 
 
Perioperative implications of consensus statement 4.  
Raised local intra-abdominal organ pressure (e.g. insufflation during laparoscopy; intra-
abdominal organ oedema) may result in inappropriate systemic blood pressure targets aimed 
at maintaining regional organ perfusion. 
 
Consensus statement 5: The measurement of blood pressure has inherent limitations 
due to inaccurate values and/or interpretation.  
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On physiological and sampling frequency grounds alone,38 gold-standard measurement of 
arterial pressure necessitates an intra-arterial catheter,39 taking into account several well 
established factors including the site of catheter placement, waveform damping and catheter 
dimensions.  Manual mercury sphygmomanometry remains the gold standard to assess the 
accuracy of automated oscillometric devices, the most widely used technique in the 
perioperative setting to measure arterial blood pressure (ABP). Manually measured blood 
pressures often differ from those obtained using automated devices and this 
adversely influences correct BP classification. Although easy to use, two key inaccuracies are 
likely to contribute to the variability in measurement of cuff ABP.40 First, fixed deflation 
rates (typically 2 mmHg.s-1) set a limit of resolution that is dependent on incident heart rate. 
Second, the measurement of the maximal rate of pressure rise during arterial pressure 
oscillation throughout the cardiac cycle is imprecise. The pressure level at which the rate of 
rise is maximal defines mean arterial pressure; a proprietary algorithm uses this value to 
estimate systolic and diastolic blood pressure.41 Absolute blood pressure level, differences in 
blood pressure between left and right arms, variability between different devices/ 
manufacturers, cuff size, posture, environment and ambient temperature may all adversely 
affect accuracy.41 Failing to take these limitations into account may lead to iatrogenic harm 
when single or intermittent measurements shape clinical decisions. 
 
Perioperative implications of consensus statement 5.  
The site and mode of blood pressure management yield different values. Accordingly, clinical 
management (including blood transfusion and vasopressor use) may alter, as suggested by 
observational database studies.42 
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Consensus statement 6: Ambulatory blood pressure measurement is the optimal method 
to establish baseline blood pressure values.  
Guidelines from multiple international bodies recommend that adults with elevated 
ABP in a clinical setting should undergo ambulatory measurements to exclude white coat 
hypertension before diagnosis.43-46 Ambulatory blood-pressure measurements are a stronger 
predictor of all-cause and cardiovascular mortality than one-off  blood-pressure 
measurements made in clinics. However, masked hypertension47  is associated with higher 
mortality than overt hypertension.48 Ambulatory blood pressure measurement also reduces 
the risk of misdiagnosing hypertension, which may occur in up to 18% of the general 
population when clinic or home based measurements are made.49 Inappropriate treatment of 
apparent white coat hypertension phenomenon after a clinic-based measurement has been 
associated with adverse outcomes, chiefly through hypotension.50,51  A further ~15-30% 
patients exhibit masked hypertension,  where clinic measurements are normal but breach 
hypertension thresholds outside the clinical setting.52 The Ambulatory Blood Pressure 
Collaboration in Patients With Hypertension meta-analysis found that both a blunted 
nocturnal decline (dipping) in arterial blood pressure and more extreme dipping in untreated 
hypertensives were associated with excess cardiovascular morbidity and mortality, 
independent of ambulatory blood pressure measurements averaged over 24 hours.   
Perioperative implications of consensus statement 6.  
Intraoperative ABP management is frequently based on a very limited number of 
preoperative readings that are unlikely to be a true representation of an individual’s chronic 
blood pressure control. The hypertension literature implies that a non-representative 
preoperative, one-off, clinic-based blood pressure values is likely to be misleading in more 
than 30% of patients. 
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Consensus statement 7: Blood pressure targets may change over time for any individual 
patient. 
With advancing age, a U-shaped association develops between systolic blood pressure and all 
cause mortality.53 These observational data challenge the findings of the SPRINT trial, 
reinforcing the view that lower targets may require a more personalised approach.54 Lower 
systolic blood pressure appears to be associated with mortality linked to non-cardiovascular 
causes,53 which may reflect subclinical cardiac failure/deconditioning.55, 56 In the acute 
setting, the perioperative period is characterized by heterogenous metabolic demands across 
disease states and different organs.57 Fixed blood pressure targets may lead to unintended 
adverse effects of interventions, since they are likely to be incompatible with maintaining a 
state of haemodynamic coherence, where macro and micro-circulatory flow are matched.31 
Additionally, the arterial baroreflex also plays an important role in long-term control of 
arterial pressure.58 Impaired blood pressure responses through loss of baroreflex sensitivity, a 
key autonomic regulatory mechanism, are associated with poorer perioperative outcomes59 
and linked mechanistically with organ injury.60, 61 The loss of hemodynamic coherence may 
occur (Figure 4) in a highly heterogeneous, organ-specific pattern.  
 
Perioperative implications of consensus statement 7.  
Dynamic perioperative alterations in blood pressure regulation require repeated evaluation of 
clinical targets. Therefore, blood pressure management therefore requires repeated, 
contextualised assessment of systemic targets in conjunction with other clinical 
haemodynamic parameters (e.g. cardiac output monitoring) and markers of organ perfusion, 
including metabolites (e.g. lactate), enzyme function (hepatic transferases), and biomarkers 
for injury (e.g. troponin, B-type natriuretic peptide).  
17 
 
Research recommendations 
From the consensus points developed above, we recommend that further research relevant to 
the perioperative period should include: 
1. Evolution of methods for non-invasive, continuous arterial pressure measurements.  
2. Determining the impact of perioperative blood pressure therapies on autoregulatory, 
microcirculatory and autonomic control.  
3. Developing methods to evaluate regional perfusion pressures, to enable the assessment of 
individualised organ responses to alterations in arterial blood pressure control.  
4. To identify sensitive, specific and continuous measures of cellular function, that enable a 
more refined evaluation of blood pressure management. 
 
Strengths and limitations 
POQI uses an established modified Delphi process which has been used in over 25 ADQI and 
POQI conferences in the last 20 years. The combination of a literature review with expert 
opinion aims to produce a practical consensus statement focussing on areas of clinical 
uncertainty. This methodology does not incorporate a formal systematic review or meta-
analysis. As the literature search and review were conducted by multi-disciplinary group 
members with expertise in this area, omission of literature of significance to this topic is 
unlikely. We acknowledge that by primarily focusing on perioperative issues,  many complex 
areas of blood pressure (patho)physiology have been considered briefly. However, as this 
process is based partly on expert opinion, there remains some risk of bias. Areas of 
uncertainty have been clearly signposted in the discussions accompanying each statement. 
 
18 
 
Summary 
Changes in the management of perioperative blood pressure are very likely given the shifting 
clinical landscape in diagnosis and management of chronic arterial blood pressure control.  
However, there is a current lack of evidence linking the latest international guidelines on 
chronic management of blood pressure with targets for perioperative practice. Inevitably, this 
has major implications for perioperative medicine, and reinforces the need to refine our 
understanding and management of this complex physiological measure in the perioperative 
period. 
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Figure Legends 
Figure 1. Variation in arterial pressure by site of measurement. Simultaneously measured 
arterial pressure waveforms from the radial artery, femoral artery and ascending aorta. While 
diastolic and mean arterial pressures are similar regardless of the site at which arterial 
pressure is measured, systolic pressure increases as the monitoring site is further away from 
the ascending aorta. 
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Figure 2. Autoregulation of blood flow. Schematic diagram showing altered relationship 
between flow and arterial pressure in normotensive and hypertensive individuals. 
Autoregulation allows optimal blood flow to be maintained for a wide range of BP values. 
Autoregulation is present also in hypertensive individuals, but the lower limit for BP is higher 
and the curve is shifted to the right compared to healthy subjects. Blood flow outside the 
autoregulation areas leads to either excessive vasoconstriction and impaired microcirculation, 
or to low blood flow and hypoperfusion. 
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Figure 3. Arterial input pressure and flow.  
A. Theoretical relationship between pressure and flow (black line) showing the 
autoregulation of vascular tone to sustain a constant blood flow despite varying arterial input 
pressures. The orange dashed lines illustrate how changes in vascular tone alter the 
relationship between instantaneous arterial input pressure and blood flow subject to 
autoregulation. The point at which arterioles spontaneously collapse (zero blood flow) 
limiting arterial pressure drop is referred to as the critical closing pressure (Pcc), which also 
varies with changes in vasomotor tone.  
B. Theoretical vascular pressure profile throughout the circulatory tree.   Mean arterial 
pressure (MAP) is constant for most of the arterial tree since larger arteries serve mainly as 
vascular capacitors holding stored blood under pressure. By contrast, vascular pressure drops 
rapidly once blood reaches smaller arteries that branch into arterioles and precapillary 
sphincters. The vascular waterfall is approximated by the critical closing pressure (Pcc) 
mirroring how water flowing over a waterfall is unaffected by how far it falls once over the 
edge. Thus, the decline in pressure from arterioles to venules, or changes in downstream 
venous pressure, does not influence either arterial pressure or blood flow. Mean systemic 
filling pressure (Pmsf) represents the upstream pressure driving venous return 
against a downstream central venous pressure (CVP).  
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Figure 4. Microcirculation and arterial pressure. 
Microcirculatory conditions where control of arterial blood pressure under conditions of hypo 
or hypertension impairing tissue perfusion, is not effective in improving microcirculatory 
perfusion. Such conditions occurs when there is a loss of hemodynamic coherence 
characterized by normalized systemic hemodynamic variables but persistent microcirculatory 
dysfunction leading to a lack of oxygen availability in tissue (as indicated by blue cells). Four 
distinct aetiologies of hemodynamic incoherence leading to microcirculatory shock can be 
considered. Type 1: heterogeneous perfusion of the microcirculation as seen in septic patients 
with obstructed capillaries next to perfused capillaries resulting in a heterogeneous 
oxygenation of the tissue cells. Type 2: haemodilution with the dilution of microcirculatory 
blood resulting in the loss of erythrocyte-filled capillaries and increasing diffusion distance 
between RBCs in the capillaries and the tissue cells. Type 3: stasis of microcirculatory 
erythrocyte flow induced by altered systemic variables (e.g. increased arterial vascular 
resistance (R) and or increased venous pressures caused by tamponade). Type 4: alterations 
involve oedema caused by capillary leak syndrome and which results in increased diffusion 
distances from 
the red blood 
cells to the 
tissues and 
reduced 
ability of the 
oxygen to 
reach the 
tissue cells. 
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